Rising Demand: Oncology Nutrition Market Expectations 2023-2033

BySanket Badgujar
Oncology Nutrition Market

The global oncology nutrition market is poised for remarkable growth, with projections indicating a surge from USD 2.07 billion in 2023 to an estimated USD 4.87 billion by 2033. This significant expansion is expected to be driven by a multitude of factors, including an increasing emphasis on medical nutrition therapy for cancer patients and a rising demand for innovative oncology nutrition products.

According to recent market analysis, the demand for oncology nutrition is forecasted to experience a robust Compound Annual Growth Rate (CAGR) of 8.9% during the forecast period. Oncology nutrition plays a pivotal role in enhancing physical capacity, supporting patients in coping with cancer therapies, and ultimately improving overall quality of life.

Report Sample Comprehensive Insights: https://www.futuremarketinsights.com/reports/sample/rep-gb-14411

One of the key drivers propelling the growth of the oncology nutrition market is the escalating need for nutritional interventions among cancer patients, particularly those experiencing a decline in tolerance to cancer therapy. This trend is anticipated to bolster the adoption of oncology nutrition products, as businesses focus on meeting the evolving requirements of this demographic.

Additionally, the market is witnessing a notable shift towards the development of elemental formulations and innovative non-GMO-based formulas, catering to the specific dietary needs of cancer patients. Furthermore, there is a growing preference for enteral nutrition over parenteral nutrition, reflecting a broader trend towards more patient-friendly and effective nutritional delivery methods.

The increasing incidence of cancer cases, coupled with a rising number of patients receiving treatment for malnutrition, further underscores the importance of oncology nutrition in contemporary healthcare practices. Moreover, the homecare industry is experiencing a surge in demand for nutritional feeding solutions, driving the expansion of the oncology nutrition market into new segments.

As the market continues to evolve, there is a growing emphasis on improving the quality of clinical research on nutritional interventions, aiming to enhance treatment outcomes and patient satisfaction.

In summary, the oncology nutrition market is poised for significant growth, fueled by the increasing recognition of the importance of nutritional therapy in cancer care. With innovative product developments and a focus on meeting the diverse needs of cancer patients, businesses operating in this space are well-positioned to capitalize on emerging opportunities and make a meaningful impact on patient outcomes.

Key Takeaways: Oncology Nutrition Market

  • North America Dominates: The region leads the market due to high cancer rates and advanced healthcare facilities, with the US market valued at around USD412.6 million.
  • Asia Pacific on the Rise: This region is expected to see the fastest growth due to an increasing number of cancer cases and rising awareness about oncology nutrition.
  • Europe’s Steady Growth: The European market is projected to reach USD0.55 billion by 2033, driven by government initiatives, new product launches, and partnerships.
  • US Market Strength: The US holds nearly 30% of the global market share, with demand further fueled by increasing cancer treatment spending and technological advancements.
  • China’s Potential: China’s oncology nutrition market is expected to reach USD165 million by 2026, reflecting a strong CAGR of 11.9%.
  • Other Notable Markets: Japan and Canada show promising growth rates of 7.4% and 7.1% respectively.
  • Latin America’s Expansion: This region is anticipated to grow at a steady CAGR of 7.6%.
  • Asia Pacific Market Size: The Asia Pacific oncology nutrition market is expected to reach USD19.2 million, driven by growth in Australia, India, and South Korea.

Competitive Landscape of the Oncology Nutrition Market:

The primary focus of top oncology nutrition firms globally lies in securing regulatory approvals, innovating cutting-edge products, launching new offerings, and engaging in strategic partnerships and acquisitions. These strategies are expected to drive expansion in the global oncology nutrition market. Here are some expansion tactics employed by companies in this sector:

  • Nestle bolstered its presence in medical nutrition by acquiring the Allergan business in January 2020.
  • Smartfish AS and B. Braun collaborated to introduce Remune, a medicinal nutrition solution, in September 2019. By 2020, B. Braun had successfully launched Remune in over 20 countries across Europe, Asia, and South America, with further market expansions underway.

Key Players in the Oncology Nutrition Market:

  • FMC Corporation
  • Danone India
  • Abbott
  • Aceto
  • B. Braun Melsungen AG
  • Baxter
  • Fresenius Kabi AG
  • Global Health Products, Inc.
  • Hormel Foods Corporation
  • Mead Johnson & Company, LLC
  • Meiji Holdings Co., Ltd
  • Nestlé S.A.
  • BioSig Technologies, Inc.
  • Auris Health, Inc.

Key Segments:

By Cancer Type:

  • Head & Neck Cancer
  • Stomach & Gastrointestinal Cancers
  • Blood Cancer
  • Breast Cancer
  • Lung Cancer
  • Other cancers

By End Use:

  • Hospitals & Clinics
  • Home Care
  • Others

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa